IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
| Number | Title | Person with Duty to Submit | Receipt Date |
|---|---|---|---|
| 10 | Settlement of Lawsuit (Charging More Than Certain Amount) | 2026-08-14 | |
| 9 | Release from designation as Investment Alert Issue & Prior notice on Re-designation | 2026-08-13 | |
| 8 | [Revised]Material Management Information related to Judgment of Investment(사업반환청구의 소 제기의 건) | 2026-08-13 | |
| 7 | Prior notice on trade suspension | 2026-08-11 | |
| 6 | [Revised]Lawsuit (Charging More Than Certain Amount) | 2026-08-06 | |
| 5 | Settlement of Lawsuit (Charging More Than Certain Amount) | 2026-08-05 | |
| 4 | Designation as Investment Alert Issue | 2026-07-29 | |
| 3 | Advance notice for assignment of issue for abnormal rise | 2026-07-28 | |
| 2 | Decision on Provision of Collateral for Others | 2026-07-07 | |
| 1 | Material Management Information related to Judgment of Investment(Study Results)(COVID-19 예방 백신 AdCLD-CoV19-1 OMI의 제3상 임상시험 결과) | 2026-06-26 |
